Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a risk factor for atherosclerotic cardiovascular disease – and now plans to move ahead ...
© 1998-2026 UEFA. All rights reserved. The UEFA word, the UEFA logo and all marks related to UEFA competitions, are protected by trademarks and/or copyright of UEFA ...
Abstract: This paper details the design of a three-phase transmitter-receiver topology for use in a dynamic wireless power transfer (DWPT) system for heavy-duty electric vehicles. The proposed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback